A consortium led by Interserve Investments is the only remaining bidder for the £687 million contract to provide cancer services in Staffordshire.
Interserve Investments’ consortium also includes The Royal Wolverhampton Hospitals NHS Trust and the University Hospitals of North Midlands NHS Trust.
The two trusts were originally each separate bidders and among the five parties who made it through the pre-qualification stage for the contract before teaming up with Interserve Investments.
CSC Computer Sciences and United Health UK were the other two organisations to pre-qualify. Both, however, pulled out of the process.
In a statement to HSJ, the clinical commissioning groups tendering the contract said: "During the competitive dialogue with bidders on the programme, a number of individual organisations and providers came together and formed a bidding consortium.
"This brings together the public and private sector, including two local NHS trusts.
"It will bring together a wide range of skills and expertise to implement this innovative approach to the commissioning of cancer care.
"The consortium is the last remaining bidder."
The consortium has to submit a formal proposal over the next few months before the contract is awarded in December.
The cancer services contract is one half of a wider procurement process, worth £1.2 billion in total, being carried out by the four local clinical commissioning groups (CCGs). An end-of-life contract, with a value of £535 million, is also being tendered out.
Cannock Chase CCG, North Staffordshire CCG, Stafford & Surrounds CCG and Stoke-on-Trent CCG are the four CCGs tendering out the two contracts.
NHS Strategic Projects Team is running the process.